Monograph
V03AC02 - Deferiprone |
Propably not porphyrinogenic |
PNP |
Rationale
Non-CYP metabolism.
Chemical description
Bidentate ligand which binds iron. Used for treatment of iron excess in thalassemia, and in cases where deferoxamine has given rise to toxic reactions. Excreted in unchanged form, as glucuronide and as iron-ferioprone complex.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Deferiprone Lipomed 500 mg filmomhulde tabletten · Ferriprox 100 mg/ml, vloeistof voor oraal gebruik · Ferriprox 1000 mg, filmomhulde tabletten · Ferriprox, 500 mg filmomhulde tabletten 
Deferiprone Lipomed 500 mg compr. pellic. · Ferriprox 1 000 mg compr. pellic. · Ferriprox 100 mg/ml sol. buv. · Ferriprox 500 mg comp. 
Ferriprox · Ferriprox 100 mg/ml Solucion Oral 
Deferiprone · Ferriprox 
DEFERIPRONE LIPOMED 500 mg 
Deferiprone · Ferriprox 
Deferipron Orifarm · Deferiprone Lipomed · Ferriprox 
Ferriprox 
Deferiprone Lipomed · Ferriprox 
Ferriprox 
Deferiprone Lipomed · Ferriprox 
Deferiprone Lipomed · Ferriprox 
Deferiprone Lipomed · Ferriprox
© NAPOS 2025